Is anti-D antibody clinically significant? A guide to Rhesus incompatibility
•
4 min read
The incidence of severe hemolytic disease of the fetus and newborn (HDFN) has drastically declined by over 90% since the introduction of anti-D prophylaxis in the 1970s. This remarkable progress highlights why understanding the question, 'Is anti-D antibody clinically significant?', is of immense importance in modern medicine.
